T-Therapeutics
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Granta Granta Park, Cambridge, Cambrid...Phone Number
+44 1223961480Website
www.t-therapeutics.comRevenue
$16.5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About T-Therapeutics
T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge. The company was created to harness the power of T cell biology, to create safe and effective treatments for cancer and autoimmune disease. T-Therapeutics' experienced team combines world-leading expertise in mouse genome engineering, single cell genomics, biopharmaceutical drug development, machine-learning and structural biology, anchored in a culture of creativity and collaboration. T-Therapeutics is developing optimal TCR therapeutics using its proprietary OpTiMus® discovery platform, that provides an almost unlimited source of unique, antigen-specific human TCRs. The company is developing a pipeline of first-in-class drugs that are intended to become transformative medicines, reshaping the clinical landscape for patients with cancer or autoimmune diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is T-Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on T-Therapeutics recently announced quarterly report
T-Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at T-Therapeutics
Check out if T-Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once T-Therapeutics has new funding data
Product Launch: Get notified when T-Therapeutics launches new products
Click to see if T-Therapeutics had a recent Job posting/layoffs
Check if T-Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at T-Therapeutics
Find more new buyers
Compare Similar Companies to T-Therapeutics
Compare insights from companies similar to T-Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
T-Therapeutics
$16.5M
51-200
Private
$91M
2022
N/A
Company Profile Activity
Activity Insights
T-Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
T-Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about T-Therapeutics.
T-Therapeutics financials insights
Gather financial insights about T-Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$91M
T-Therapeutics Tech Stack
A closer look at the technologies used by T-Therapeutics
See more technologies
T-Therapeutics News & Media
cellvie secures USD 5 Million to advance mitochondria-based Ttherapeutics - Venturelab
Harvard spin-off cellvie, a biotech company developing mitochondria-based therapeutics, has raised USD 5 million to advance its work in cell therapy.T-Therapeutics appoints Dr David Hung as Chairman
T-Therapeutics appoints Dr David Hung as Chairman
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding T-Therapeutics
Sign Up For FreeTo access detailed company insights
T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge. The company was created to harness the power of T cell biology, to create safe and effective treatments for cancer and autoimmune disease. T-Therapeutics' experienced team combines world-leading expertise in mouse genome engineering, single... Read More
